EICHOR
● Not Yet Recruiting
Liver Biopsy Following Gene Therapy For Hemophilia
Condition: Hemophilia A · Hemophilia B · Sponsor: St. Jude Children's Research Hospital
About this study
This observational study will obtain liver biopsy samples and evaluate the long-term effect of adeno-associated virus (AAV)-mediated gene therapy on the liver tissue in adult patients with hemophilia A or hemophilia B who have previously been treated with a factor VIII or factor IX gene-containing AAV-vector for liver-targeted gene transfer. Participants are from a cohort of patients treated with AAV-mediated gene transfer and at least 6 months after vector infusion.
This description comes directly from the study's public registry record.
Talk to the study team
Ulrike Reiss, MD · 888-226-4343 · referralinfo@stjude.org
Always discuss trial participation with your own doctor first.
Locations (1)
| St. Jude Children's Research Hospital | Memphis, Tennessee, United States | — |
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05932914